HHS Awards $48.5M for Cancer Drug Development Support to Technical Resources International
Contract Overview
Contract Amount: $48,485,098 ($48.5M)
Contractor: Technical Resources International, Inc.
Awarding Agency: Department of Health and Human Services
Start Date: 2015-07-01
End Date: 2022-06-30
Contract Duration: 2,556 days
Daily Burn Rate: $19.0K/day
Competition Type: FULL AND OPEN COMPETITION
Number of Offers Received: 1
Pricing Type: COST PLUS FIXED FEE
Sector: Healthcare
Official Description: IGF::OT::IGF TITLE - DRUG DEVELOPMENT SUPPORT FOR THE CANCER THERAPY EVALUATION PROGRAM (CTEP)
Place of Performance
Location: BETHESDA, MONTGOMERY County, MARYLAND, 20817
State: Maryland Government Spending
Plain-Language Summary
Department of Health and Human Services obligated $48.5 million to TECHNICAL RESOURCES INTERNATIONAL, INC. for work described as: IGF::OT::IGF TITLE - DRUG DEVELOPMENT SUPPORT FOR THE CANCER THERAPY EVALUATION PROGRAM (CTEP) Key points: 1. Contract awarded via full and open competition, suggesting a competitive bidding process. 2. The contract spans nearly 7 years, indicating a long-term need for these services. 3. The primary service category is 'All Other Professional, Scientific, and Technical Services', a broad area. 4. The awardee, Technical Resources International, Inc., has secured a significant portion of the contract value.
Value Assessment
Rating: fair
The contract type is Cost Plus Fixed Fee, which can lead to cost overruns if not managed carefully. Benchmarking against similar drug development support contracts is difficult without more specific service details.
Cost Per Unit: N/A
Competition Analysis
Competition Level: full-and-open
The contract was awarded under full and open competition, indicating that multiple vendors had the opportunity to bid. This method generally promotes price discovery and competitive pricing.
Taxpayer Impact: Taxpayer funds are being used for critical cancer research support, with the expectation of competitive pricing due to the procurement method.
Public Impact
Supports vital cancer therapy evaluation and drug development, potentially leading to new treatments. The long contract duration suggests ongoing government reliance on these specialized services. Funding is directed towards scientific and technical services crucial for medical research.
Waste & Efficiency Indicators
Waste Risk Score: 50 / 10
Warning Flags
- Cost Plus Fixed Fee contract type can incentivize higher costs.
- Broad service category may obscure specific cost drivers.
- Long contract duration increases exposure to potential cost increases over time.
Positive Signals
- Awarded through full and open competition.
- Supports critical cancer research initiatives.
- Long-term commitment indicates sustained program need.
Sector Analysis
This contract falls within the professional, scientific, and technical services sector, specifically supporting health and human services research. Spending in this area is crucial for advancing medical knowledge and public health.
Small Business Impact
The data does not indicate any specific set-asides for small businesses. The contract was awarded under full and open competition, suggesting larger firms may have been more likely to compete.
Oversight & Accountability
Oversight would typically be managed by the National Institutes of Health (NIH) program officials. The contract type and duration necessitate diligent monitoring to ensure cost control and performance.
Related Government Programs
- All Other Professional, Scientific, and Technical Services
- Department of Health and Human Services Contracting
- National Institutes of Health Programs
Risk Flags
- Cost Plus Fixed Fee contract type.
- Broad service category.
- Long contract duration.
- No explicit small business participation noted.
Tags
all-other-professional-scientific-and-te, department-of-health-and-human-services, md, definitive-contract, 10m-plus
Frequently Asked Questions
What is this federal contract paying for?
Department of Health and Human Services awarded $48.5 million to TECHNICAL RESOURCES INTERNATIONAL, INC.. IGF::OT::IGF TITLE - DRUG DEVELOPMENT SUPPORT FOR THE CANCER THERAPY EVALUATION PROGRAM (CTEP)
Who is the contractor on this award?
The obligated recipient is TECHNICAL RESOURCES INTERNATIONAL, INC..
Which agency awarded this contract?
Awarding agency: Department of Health and Human Services (National Institutes of Health).
What is the total obligated amount?
The obligated amount is $48.5 million.
What is the period of performance?
Start: 2015-07-01. End: 2022-06-30.
What specific drug development activities are covered under this contract, and how do they align with NIH's strategic research priorities?
The contract supports the Cancer Therapy Evaluation Program (CTEP), which focuses on the clinical development of novel anti-cancer agents. Activities likely include preclinical testing, clinical trial support, and data analysis. Alignment with NIH priorities is high, as CTEP is a core component of the National Cancer Institute's mission to reduce the burden of cancer.
What are the key performance indicators (KPIs) used to measure the success of Technical Resources International, Inc. in supporting drug development?
Key performance indicators would likely focus on milestones achieved in drug development pipelines, adherence to regulatory standards, timely completion of preclinical and clinical study phases, and the quality of data generated. Effective management by NIH would involve regular reviews of progress against these KPIs.
How does the Cost Plus Fixed Fee structure incentivize efficiency and cost control for this long-term drug development support contract?
The Cost Plus Fixed Fee structure provides a fixed profit margin regardless of the final cost, which can reduce the incentive for the contractor to control costs aggressively. NIH oversight is critical to scrutinize costs and ensure they are reasonable and allocable to the contract's objectives. Without strong oversight, this structure can lead to higher overall spending.
Industry Classification
NAICS: Professional, Scientific, and Technical Services › Other Professional, Scientific, and Technical Services › All Other Professional, Scientific, and Technical Services
Product/Service Code: SUPPORT SVCS (PROF, ADMIN, MGMT) › ADMINISTRATIVE SUPPORT SERVICES
Competition & Pricing
Extent Competed: FULL AND OPEN COMPETITION
Solicitation Procedures: NEGOTIATED PROPOSAL/QUOTE
Solicitation ID: N02CM4100727
Offers Received: 1
Pricing Type: COST PLUS FIXED FEE (U)
Evaluated Preference: NONE
Contractor Details
Address: 6500 ROCK SPRING DR STE 650, BETHESDA, MD, 20817
Business Categories: Category Business, Corporate Entity Not Tax Exempt, Hispanic American Owned Business, Minority Owned Business, Not Designated a Small Business, Special Designations, U.S.-Owned Business, Woman Owned Business
Financial Breakdown
Contract Ceiling: $55,311,391
Exercised Options: $48,485,098
Current Obligation: $48,485,098
Actual Outlays: $5,968,036
Contract Characteristics
Commercial Item: COMMERCIAL PRODUCTS/SERVICES PROCEDURES NOT USED
Cost or Pricing Data: YES
Timeline
Start Date: 2015-07-01
Current End Date: 2022-06-30
Potential End Date: 2022-09-30 00:00:00
Last Modified: 2024-11-13
More Contracts from Technical Resources International, Inc.
- Clinical Services Network- Clinical Trial Planning and Execution — $317.1M (Department of Health and Human Services)
- Clinical Research Operations and Management Support (croms) — $173.3M (Department of Health and Human Services)
- TAS::75 0885::TAS Dmid Clinical Research Operations and Management Support (croms) — $124.8M (Department of Health and Human Services)
- Niaid/Division of Aids: Regulatory Support Center — $105.4M (Department of Health and Human Services)
- CRO Assistance for the Activ-1 Master Protocol — $74.5M (Department of Health and Human Services)
View all Technical Resources International, Inc. federal contracts →
Other Department of Health and Human Services Contracts
- Contact Center Operations (CCO) — $5.5B (Maximus Federal Services, Inc.)
- TAS::75 0849::TAS Oper of Govt R&D Goco Facilities — $4.8B (Leidos Biomedical Research Inc)
- THE Purpose of This Contract IS to Provide the Full Complement of Services Necessary to Care for UC in ORR Custody Including Facilities Set-Up, Maintenance, and Support Internal and Perimeter (IF Applicable) Security, Direct Care and Supervision Inc — $3.5B (Rapid Deployment Inc)
- Contact Center Operations — $2.6B (Maximus Federal Services, Inc.)
- Federal Contract — $2.4B (Leidos Biomedical Research Inc)
View all Department of Health and Human Services contracts →